Bobon D, Ansseau M
Pharmacopsychiatry. 1986 Mar;19(2):55-7. doi: 10.1055/s-2007-1017153.
The AMDP-system, elaborated by the Association for Methodology and Documentation in Psychiatry, comprises three anamnestic forms and two rating scales on present psychopathological and somatic states. Moreover, three subscales have been developed in order to assess more specifically anxiety, manic/depressive, and schizophrenic symptomatology. The psychometric properties of the AMDP-system (interrater reliability, validity, homogeneity, sensitivity) and its availability in most European languages make it an ideal instrument for the assessment of clinical changes in drug trials, with the possibility of using the comprehensive scale for the early evaluation of a new drug and of reserving the short subscales for later clinical development.
由精神病学方法与文献协会精心编制的AMDP系统,包含三种既往症表格以及两份关于当前精神病理学和躯体状况的评定量表。此外,还开发了三个分量表,以便更具体地评估焦虑、躁狂/抑郁和精神分裂症症状。AMDP系统的心理测量特性(评分者间信度、效度、同质性、敏感性)以及它在大多数欧洲语言中的可用性,使其成为评估药物试验临床变化的理想工具,既可以使用综合量表对新药进行早期评估,也可以保留简短分量表用于后期临床开发。